Gabapentin Tablet, Film Coated
Product Images NDC 80425-0036

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin 800mg Tab Qty 30 Ndc 80425 0036

This is a package of Gabapentin tablets with a strength of 500 mg and a quantity of 20 tablets. The manufacturer is AAdvnncnd and the tablets are intended for nasal consumption. The identification code on the package is 30ABB001221.*

FDA Label Image

Gabapentin 800mg Tab Qty 60 Ndc 80425 0036

This is a label for a medication called Gabapentin, in tablet form. The pack contains 60 tablets and is packed by a company called AAdvancnd. There is an identifying number provided, which appears to be 001223.*

FDA Label Image

Image 1

FDA Label Image

Image 3

The text provides a chart showing the weekly mean pain scores observed in the ITT population, in a study where a placebo and a dosage of 3600 mg/day of gabapentin were administered for 4 weeks, followed by a 4-week fixed dose period. No further information is available.*

FDA Label Image

Image 4

This appears to be a figure description of a pain study, referencing weekly mean pain scores for two different treatment periods (a 3-week dose titration period followed by a 4-week fixed dose period) for placebo and two doses of gabapentin. The figure includes a baseline and 7 subsequent weeks of data.*

FDA Label Image

Image 5

The text describes a figure showing the percentage of patients who responded to treatment by experiencing a 250% reduction in pain score in controlled studies of Postherpetic Neuralgia (PHN). The figure shows a 100% response rate. The chart also indicates that two studies were performed in which 20 and 12 percent of patients responded, respectively. The treatments used in the studies were PBO, BP 3600, GBP1800 and GBP200.*

FDA Label Image

Image 6

The text provides a figure description regarding the responder rate of Gabapentin in patients above 12 years of age with partial seizures. The figure displays the difference in responder rate between Gabapentin and placebo by dose and study. The daily doses of Gabapentin evaluated are 600, 900, 1200, and 1800 mg. No additional information is available.*

FDA Label Image

Image

This text appears to be describing a formula or equation for calculating a value called "Lt" using the variables of age in years, weight in kilograms, and creatinine levels. However, without further context or information it is unclear what this value represents or how it might be used.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.